Dermira, Inc. (DERM) Social Stream



Dermira, Inc. (DERM): $3.80

0.22 (-5.47%)

POWR Rating

Component Grades

Momentum

NR

Stability

NR

Sentiment

Quality

NR

Add DERM to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked


in industry

JOURNEY MEDICAL CORP (DERM) Price Targets From Analysts

Use the tables below to see what analysts covering JOURNEY MEDICAL CORP think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-07 1 $14 $14 $14 $5.05 177.23%
2022-01-13 3 $17 $14 $15.5 $5.05 206.93%
2022-05-11 3 $17 $9 $13.333 $5.05 164.02%
2022-07-25 3 $12 $9 $10.333 $5.05 104.61%
2022-08-10 3 $10 $8 $9 $5.05 78.22%
2022-10-03 3 $10 $7 $8.666 $5.05 71.6%
2022-11-11 3 $7 $6 $6.666 $5.05 32%
2022-11-18 2 $7 $6 $6.333 $5.05 25.41%
2023-03-31 3 $7 $6 $6.333 $5.05 25.41%
2023-05-23 2 $4 $3 $3.5 $5.05 -30.69%
2023-05-24 3 $7 $3 $4.666 $5.05 -7.6%
2023-07-12 2 $6 $4 $5 $5.05 -0.99%
2023-11-08 2 $7 $6 $6.5 $5.05 28.71%
2023-12-07 1 $8 $8 $8 $5.05 58.42%
NA 1 $NA $NA $NA $5.05 NA%

The Trend in the Analyst Price Target


Over the past 13 months, DERM's average price target has gone up $0.67.

DERM reports an average of 132.23% for its upside potential over the past 36 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-23 2 4 3 3.500 1.24 182.26%
2023-05-24 3 7 3 4.666 1.24 276.29%
2023-08-09 2 7 6 6.500 2.44 166.39%
2023-12-07 1 8 7 7.500 6.68 12.28%
2023-12-07 1 8 8 8.000 6.68 19.76%

DERM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 19 months, DERM's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how JOURNEY MEDICAL CORP fares relative to all US stocks, note that its number of analysts covering the stock is greater than 100.99% of that group.
  • JOURNEY MEDICAL CORP's average analyst price target is greater than 199.85% of all US stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, JOURNEY MEDICAL CORP's variance in analysts' estimates is lower than -247.07% of them.
  • DERM has a higher upside potential (average analyst target price relative to current price) than 637.22% of stocks in the micro market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to JOURNEY MEDICAL CORP are DYAI, ENTX, and GENE.

What is the outlook for DERM? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!